Ngā hua rapu - Marcel Reiser
- E whakaatu ana i te 1 - 17 hua o te 17
-
1
-
2
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the GermanHig... mā A. Wunderlich, Marita Kloess, Marcel Reiser, Christian Rudolph, Lorenz Truemper, Stefan Bittner, Harald Schmalenberg, Rudolf Schmits, Michael Pfreundschuh, Markus Loeffler
I whakaputaina 2003Artigo -
3
Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease mā Andreas Josting, Christian Rudolph, Marcel Reiser, MY Mapara, M. Sieber, Hartmut Kirchner, Bernd Dörken, Dieter K. Hossfeld, Volker Diehl, Andreas Engert
I whakaputaina 2002Artigo -
4
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma mā H. Schulz, Julia Bohlius, Nicole Skoetz, Sven Trelle, Thilo Kober, Marcel Reiser, Martin Dreyling, Michael Herold, Guido Schwarzer, Michael Hallek, Andreas Engert
I whakaputaina 2007Revisão -
5
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG) mā H. Schulz, U. Rehwald, Franck Morschhauser, Thomas Elter, Christoph Driessen, Thomas Rüdiger, Peter Borchmann, Roland Schnell, Volker Diehl, Andreas Engert, Marcel Reiser
I whakaputaina 2007Artigo -
6
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study... mā U. Rehwald, H. Schulz, Marcel Reiser, Markus Sieber, Jan Oliver Staak, Franck Morschhauser, Christoph Driessen, Thomas Rüdiger, Konrad Müller-Hermelink, Volker Diehl, Andreas Engert
I whakaputaina 2002Artigo -
7
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients mā Gerd Fätkenheuer, Albert Theisen, Jürgen K. Rockstroh, Tanja Grabow, Christian Wicke, Katja Becker, Ulrike Wieland, Herbert Pfister, Marcel Reiser, P Hegener, Caspar Franzen, Achim Schwenk, Bernd Salzberger
I whakaputaina 1997Carta -
8
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multip... mā Elke Pogge von Strandmann, Hinrich P. Hansen, Katrin S. Reiners, Roland Schnell, Peter Borchmann, Sabine Merkert, Venkateswara R. Simhadri, Andreas Draube, Marcel Reiser, Ingvill Purr, Michael Hallek, Andreas Engert
I whakaputaina 2005Artigo -
9
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL mā Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser
I whakaputaina 2012Artigo -
10
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma mā A. Herrmann, Eva Hoster, Thomas Zwingers, Günter Brittinger, M. Engelhard, P. Meusers, Marcel Reiser, Roswitha Forstpointner, Bernd Metzner, Norma Peter, Bernhard Wörmann, Lorenz Trümper, Michael Pfreundschuh, Hermann Einsele, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling
I whakaputaina 2008Artigo -
11
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lympho... mā Agnieszka Korfel, Thomas Elter, E. Thiel, Matthias Hänel, Robert Möhle, Roland Schroers, Marcel Reiser, M. Dreyling, Jan Eucker, Christian W. Scholz, Bernd Metzner, Alexander Röth, J. Birkmann, Uwe Schlegel, P. Martus, Gerald Illerhaus, L. Fischer
I whakaputaina 2012Artigo -
12
Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial mā Thomas Elter, Peter Borchmann, H. Schulz, Marcel Reiser, Sven Trelle, Roland Schnell, Markus Jensen, Peter Staib, Timo Schinköthe, H. Stützer, Jürgen Rech, Martin Gramatzki, Walter E. Aulitzky, Ibrahim Hasan, Andreas Josting, Michael Hallek, Andreas Engert
I whakaputaina 2005Artigo -
13
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia mā Petra Langerbeins, Can Zhang, Sandra Robrecht, Paula Cramer, Moritz Fürstenau, Othman Al‐Sawaf, Julia von Tresckow, Anna‐Maria Fink, Karl‐Anton Kreuzer, Ursula Vehling‐Kaiser, Eugen Tausch, Lothar Müller, Michael J. Eckart, Rudolf Schlag, W. Freier, Tobias Gaska, Christina Balser, Marcel Reiser, Martina Stauch, Clemens‐Martin Wendtner, Kirsten Fischer, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek
I whakaputaina 2021Artigo -
14
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-... mā Frank Griesinger, Wilfried Eberhardt, Arnd Nusch, Marcel Reiser, Mark‐Oliver Zahn, Christoph Maintz, Christiane Bernhardt, Christoph Losem, Albrecht Stenzinger, Lukas C. Heukamp, Reinhard Büttner, Norbert Marschner, Martina Jänicke, A. Fleitz, Lisa Spring, Jörg Sahlmann, Aysun Karatas, A. Hipper, Wilko Weichert, Monika Heilmann, Parvis Sadjadian, Wolfgang Gleiber, Christian Grah, Cornelius F. Waller, Martin Reck, Achim Rittmeyer, Petros Christopoulos, Martin Sebastian, Michael Thomas
I whakaputaina 2020Artigo -
15
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer mā Hans‐Ulrich Schildhaus, Lukas C. Heukamp, Sabine Merkelbach‐Bruse, Katarina Riesner, Katja Schmitz, Elke Binot, Ellen Paggen, Kerstin Albus, Wolfgang Schulte, Yon‐Dschun Ko, Andreas Schlesinger, Sascha Ansén, Walburga Engel-Riedel, Michael Brockmann, Monika Serke, Ulrich Gerigk, Sebastian Huss, Friederike Göke, Sven Perner, Khosro Hekmat, Konrad Frank, Marcel Reiser, Roland Schnell, Marc Bos, Christian Mattonet, Martin L. Sos, Erich Stoelben, Jürgen Wolf, Thomas Zander, Reinhard Buettner
I whakaputaina 2012Artigo -
16
A Genomics-Based Classification of Human Lung Tumors mā Danila Seidel, Thomas Zander, Lukas C. Heukamp, Martin Peifer, Marc Bos, Lynnette Fernández-Cuesta, Frauke Leenders, Xin Lü, Sascha Ansén, Masyar Gardizi, Chau Nguyen, Johannes Berg, Prudence A. Russell, Zoe Wainer, Hans‐Ulrich Schildhaus, Toni-Maree Rogers, Benjamin Solomon, William Pao, Scott L. Carter, Gad Getz, D. Neil Hayes, Matthew D. Wilkerson, Erik Thunnissen, William D. Travis, Sven Perner, Gavin Wright, Élisabeth Brambilla, Reinhard Buettner, Juergen Wolf, Roman K. Thomas, Franziska Gabler, Ines Wilkening, Christian Mueller, Ilona Dahmen, Roopika Menon, Katharina Koenig, Kerstin Albus, Sabine Merkelbach‐Bruse, Jana Fassunke, Katja Schmitz, Helen Kuenstlinger, Michaela Angelika Kleine, Elke Binot, Silvia Querings, Janine Altmueller, Ingelore Boessmann, Peter Nuemberg, Peter M. Schneider, Magdalena Bogus, Alex Soltermann, Holger Moch, Odd Terje Brustugun, Steinar Solberg, Marius Lund‐Iversen, Åslaug Helland, Thomas Muley, Hans Hoffmann, Philipp A. Schnabel, Yuan Chen, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Joachim H. Clement, Walter Weder, Joerg Saenger, Erich Stoelben, Corinna Ludwig, Walburga Engel-Riedel, Egbert F. Smit, Danille A. M. Heideman, Peter J.F. Snijders, Lucia Nogová, Martin L. Sos, Christian Mattonet, Karin Toepelt, Matthias Scheffler, Eray Goekkurt, Rainer Kappes, Stefan Krueger, Kato Kambartel, Dirk Behringer, Wolfgang Schulte, Wolfgang Galetke, Winfried Randerath, Matthias Heldwein, Andreas Schlesinger, Monika Serke, Khosro Hekmat, Konrad Frank, Roland Schnell, Marcel Reiser, Ali-Nuri Huenerlituerkoglu, Stephan Schmitz, Lisa Meffert, Yon‐Dschun Ko, Markus Litt-Lampe, Ulrich Gerigk, Rainer Fricke, Benjamin Besse, Christian Brambilla
I whakaputaina 2013Artigo -
17
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial mā Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Jordan M. Winter, Do‐Youn Oh, Chung–Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D. Lopez, Tanios Bekaii‐Saab, Andrew H. Ko, Armando Santoro, Joon Oh Park, Marcus Smith Noel, Giovanni Luca Frassineti, Yan‐Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan Berlin, Philip Philip, Malcolm J. Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, Andrew V. Biankin, Michele Reni, Richard A. Epstein, Paul L. Vasey, Jeremy Shapiro, Matthew Burge, Yu Jo Chua, Marion Harris, Nick Pavlakis, Niall C. Tebbutt, Gerald W. Prager, Christian Dittrich, Alois Lang, Kathrin Philipp‐Abbrederis, Richard Greil, Herbert Stöger, Michael Girschikofsky, Thomas Kuehr, Jean–Luc Van Laethem, Stéphanie Laurent, Neesha C. Dhani, Yoo Joung Ko, Scot Dowden, Petr Kavan, Mustapha Édouard Tehfe, Eugen Kubala, Milan Kohoutek, Per Pfeiffer, Mette Yilmaz, Vibeke K. Parner, Tapio Salminen, Leena‐Maija Soveri, Eija Korkeila, Pia Österlund, Julien Taı̈eb, David Tougeron, Pascal Artru, François‐Xavier Caroli‐Bosc, Rosine Guimbaud, Anthony Turpin, Thomas Walter, Jean‐Baptiste Bachet, Volker Kunzmann, Florian Kreth, Andreas De Block, Marino Venerito, Helmut Oettle, Meinolf Karthaus, Jörg Trojan, Gunnar Folprecht, Markus M. Lerch, Frank Kullmann, Marcel Reiser, Volker Heinemann, Marcus‐Alexander Wörns, H. Schulz, Benjamin Garlipp, Thomas Yau, Lam Stephen Chan, Balázs Juhász, László Landherr, Tamás Pintér, G. Bodoky, Zsuzsanna Kahán, Ray McDermott, Derek G. Power, Luca Gianni, Salvatore Siena, Michèle Milella, Alfredo Falcone, Rossana Berardi
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Oncology
Chemotherapy
Lymphoma
Gastroenterology
Rituximab
Surgery
Cancer
Immunology
Adverse effect
Biochemistry
Biology
Cancer research
Cyclophosphamide
Genetics
Lung cancer
Pathology
Randomized controlled trial
Regimen
Transplantation
Adenocarcinoma
Astrobiology
CHOP
Carcinoma
Chemistry
Chemotherapy regimen
Chronic lymphocytic leukemia
Cytarabine
Etoposide